3Jaenen N, Baudouin C, Pouliquen P, et al.Ocular symptoms andsigns with preserved and preservative-free glaucoma medications[J].Eur J Ophthalmol,2007,17:341-349. 被引量：1
4De Jong C, Stolwijk T, Kuppens E, et al.Topical timolol withand without benzalkonium chloride:epithelial permeability andautofluorescence of the cornea in glaucoma [J].Graefes ArchClin Exp Ophthalmol, 1994,232:221-224. 被引量：1
5Zimmerman TJ, Hahn SR, Gelb L, et al.The effect of hyperae-mia on open-angle glaucoma(OAG) treatment [ M].Annual Meet-ing of the European Society of Ophthalmology(SOE) .9-12 June2007,Vienna, Austria,Abstract FP-GLA-036. 被引量：1
6Nordmann JP, Auzanneau N, Ricard S .Vision-related qualityof life and topical glaucoma treatment side-effects [J].HealthQual Life Outcomes, 2003,1:75. 被引量：1
7Detry-Morel M.Side-effects of glaucoma medications [J].BullSoc Beige Ophtalmol, 2006,299:27-40. 被引量：1
8Broadway DC, Grierson I,O’Brien C.Adverse effects of topicalantiglaucoma medication.II.The outcome of filtration surgery[J].Arch Ophthalmol, 1994,112:1446-1454. 被引量：1
9Broadway DC & Chang LP.Trabeculectomy, risk factors for fail-ure and the preoperative state of the conjunctiva [J].J Glauco-ma,2001,10:237-249. 被引量：1
10Schwab IR, Linberg JV, Gioia VM, et al.Foreshortening of theinferior conjunctival fornix associated with chronic glaucomamedications [J].Ophthalmology, 1992,99:197-202. 被引量：1
8Kodym A,Zawisza T,Taberska J,et al. Physicochemical and microbiological properties of eye drops containing cefuroxime[ J]. Acta Pol Pharm, 2006,63 ( 4 ) : 293 -299. 被引量：1
9Ch6dru-Legros V,Fines-Guyon M, Ch6rel A, et al. In vitro stability of fortified ophthalmic antibiotics stored at-20 degrees C for 6 months [ J ]. Cornea ,2010,29(7 ) : 807-811. doi : 10. 1097/IC0. ObO13e3181 c32573. 被引量：1
10Rojanarata T, Tankul J, Woranaipinich C, et al. Stability of fortified cefazolin ophthalmle solutions prepared in artificial tears containing surfactant-based versus oxidant-based preservatives[ J]. J Ocul Pharmacol Ther,2010,26 ( 5 ) : 485 -490. 被引量：1
